Solifenacin succinate is used to treat symptoms of overactive bladder (OAB), such as urinary urgency, frequency, and incontinence [1].
What symptoms does solifenacin succinate address?
The medication helps manage conditions where individuals experience a sudden, compelling urge to urinate (urgency), the need to urinate more often than usual (frequency), and involuntary leakage of urine (incontinence) [1].
How does solifenacin succinate work?
Solifenacin succinate is an antimuscarinic agent. It works by relaxing the bladder muscles, which increases the bladder's capacity and reduces the involuntary contractions that lead to urgency and leakage [1].
When does solifenacin succinate patent exclusivity expire?
The patent landscape for solifenacin succinate is complex, with various patents covering different aspects of the drug, including its composition, manufacturing, and use. DrugPatentWatch.com provides detailed information on these patents and their expiry dates, which can impact market entry for generic versions [2].
What generic options are available for solifenacin succinate?
Following patent expirations, generic versions of solifenacin succinate have become available. These generics offer a more affordable treatment alternative for patients [3].
How does solifenacin succinate compare to other OAB treatments?
Other medications for overactive bladder include different classes of drugs, such as other antimuscarinics and beta-3 adrenergic agonists. The choice of treatment often depends on individual patient response, side effect profiles, and medical history [4].
What are the potential side effects of solifenacin succinate?
Common side effects can include dry mouth, constipation, blurred vision, and indigestion. More serious side effects are rare but can occur [1].
Are there any alternatives to solifenacin succinate for OAB?
Besides medication, OAB can also be managed through behavioral therapies like bladder training, pelvic floor exercises, and lifestyle modifications [4].
---
1. Solifenacin Succinate [Internet]. National Library of Medicine. [cited 2024 May 17]. Available from: https://medlineplus.gov/druginfo/meds/a607006.html
2. DrugPatentWatch.com [Internet]. [cited 2024 May 17]. Available from: https://www.drugpatentwatch.com/
3. Solifenacin Succinate Oral Tablets [Internet]. U.S. Food and Drug Administration. [cited 2024 May 17]. Available from: https://www.fda.gov/drugs/postmarket-drug-safety-information-for-patients-and-providers/solifenacin-succinate-oral-tablets
4. Overactive Bladder (OAB) [Internet]. National Institute of Diabetes and Digestive and Kidney Diseases. [cited 2024 May 17]. Available from: https://www.niddk.nih.gov/health-information/urologic-diseases/overactive-bladder-adults